Liver Transplant Research Today is a free monthly online journal that collates and summarizes the latest research about Liver Transplant, including details on risks, prognosis, procedure, surgery, organ donation.

Volume 1 (2005), Issue 3 (March)

1. Minimization of immunosuppression with thymoglobuline pre-treatment and HCV recurrence in liver transplantation.
   Clin Transplant, 19(2): 255-8. [Abstract] [Full-text]
2. Gastrointestinal hemorrhage due to complicated gastroduodenal ulcer disease in liver transplant patients taking sirolimus.
   Clin Transplant, 19(2): 250-4. [Abstract] [Full-text]
3. Outflow block secondary to stenosis of the inferior vena cava following living-donor liver transplantation?
   Clin Transplant, 19(2): 215-9. [Abstract] [Full-text]
4. Predictors of improvement in renal function after calcineurin inhibitor withdrawal for post-liver transplant renal dysfunction.
   Clin Transplant, 19(2): 193-8. [Abstract] [Full-text]
5. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma.
   Clin Transplant, 19(2): 175-80. [Abstract] [Full-text]
6. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
   Aliment Pharmacol Ther, 21(5): 549-57. [Abstract] [Full-text]
7. Liver transplantation as definitive treatment for a factor V Leiden mutation.
   J Pediatr, 146(3): 418-22. [Abstract] [Full-text]
8. Risk of hepatocellular carcinoma in liver mitochondrial respiratory chain disorders.
   J Pediatr, 146(3): 414-7. [Abstract] [Full-text]
9. Liver transplantation for hepatocellular carcinoma.
   Best Pract Res Clin Gastroenterol, 19(1): 147-60. [Abstract] [Full-text]
10. Analytical approaches for transplant research, 2004.
    Am J Transplant, 5(4): 950-7. [Abstract] [Full-text]
11. Liver and intestine transplantation: summary analysis, 1994-2003.
    Am J Transplant, 5(4): 916-33. [Abstract] [Full-text]
12. A comparison of surgical outcomes and quality of life surveys in right lobe vs. left lateral segment liver donors.
    Am J Transplant, 5(4): 805-9. [Abstract] [Full-text]
13. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma.
    Am J Transplant, 5(4): 795-804. [Abstract] [Full-text]
14. Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation?
    Am J Transplant, 5(4): 788-94. [Abstract] [Full-text]
15. Successful liver and kidney transplantation from cadaveric donors with left-sided bacterial endocarditis.
    Am J Transplant, 5(4): 781-7. [Abstract] [Full-text]
16. Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism.
    Scand J Gastroenterol, 40(2): 206-16. [Abstract] [Full-text]
17. Second hepatitis C replication compartment indicated by viral dynamics during liver transplantation.
    J Hepatol, 42(4): 491-8. [Abstract] [Full-text]
18. Liver transplantation for alcoholic liver disease.
    Clin Liver Dis, 9(1): 171-81. [Abstract] [Full-text]
19. Long-term management of alcoholic liver disease.
    Clin Liver Dis, 9(1): 135-49. [Abstract] [Full-text]
20. A cluster of rotavirus enteritis in adult transplant recipients.
    Transpl Int, 18(4): 470-4. [Abstract] [Full-text]
21. Complete hepatic ischemia due to torsion of a large accessory liver lobe: first case to require transplantation.
    Transpl Int, 18(4): 467-9. [Abstract] [Full-text]
22. Weight gain and obesity after liver transplantation.
    Transpl Int, 18(4): 461-6. [Abstract] [Full-text]
23. A comparative study of resource use and costs of renal, liver and heart transplantation.
    Transpl Int, 18(4): 437-43. [Abstract] [Full-text]
24. Using a radial artery as an interpositional vascular graft in a living-donor liver transplantation for hepatocellular carcinoma.
    Transpl Int, 18(4): 408-11. [Abstract] [Full-text]
25. Maintenance of normothermia at operation room temperature of 24 degrees C in adult and pediatric patients undergoing liver transplantation.
    Transpl Int, 18(4): 396-400. [Abstract] [Full-text]
26. Impact of donor, technical, and recipient risk factors on survival and quality of life after liver transplantation.
    Arch Surg, 140(3): 273-7. [Abstract] [Full-text]
27. Management and outcome of neonatal-onset ornithine transcarbamylase deficiency following liver transplantation at 60 days of life.
    Mol Genet Metab, 84(4): 363-6. [Abstract] [Full-text]
28. Transmission of rabies virus from an organ donor to four transplant recipients.
    N Engl J Med, 352(11): 1103-11. [Abstract] [Full-text]
29. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy.
    Clin Nutr, 24(2): 288-96. [Abstract] [Full-text]
30. Human leukocyte antigens in Japanese patients with biliary atresia: retrospective analysis of patients who underwent living donor liver transplantation.
    Hum Immunol, 66(3): 295-300. [Abstract] [Full-text]
31. Reduced immunosuppression in pediatric liver-intestine transplant recipients with CD8+CD28- T-suppressor cells.
    Hum Immunol, 66(3): 252-7. [Abstract] [Full-text]
32. Rapid response to rituximab in a pediatric liver transplant recipient with post-transplant lymphoproliferative disease and maintenance with sirolimus monotherapy.
    Pediatr Transplant, 9(2): 249-53. [Abstract] [Full-text]
33. Carcinoma of donor origin after liver-intestine transplantation in a child.
    Pediatr Transplant, 9(2): 244-8. [Abstract] [Full-text]
34. Risk factors for fungal infection in paediatric liver transplant recipients.
    Pediatr Transplant, 9(2): 220-5. [Abstract] [Full-text]
35. Hypogammaglobulinemia in pediatric liver transplant recipients.
    Pediatr Transplant, 9(2): 215-9. [Abstract] [Full-text]
36. Renal function outcome in pediatric liver transplant recipients.
    Pediatr Transplant, 9(2): 201-7. [Abstract] [Full-text]
37. Invasive pneumococcal disease in pediatric organ transplant recipients: a high-risk population.
    Pediatr Transplant, 9(2): 183-6. [Abstract] [Full-text]
38. Hepatitis C is a risk factor for death after liver retransplantation.
    Liver Transpl, 11(4): 434-40. [Abstract] [Full-text]
39. Heterotopic vs. orthotopic liver transplantation for chronic liver disease: a case-control comparison of short-term and long-term outcomes.
    Liver Transpl, 11(4): 396-401. [Abstract] [Full-text]
40. Immunosuppression and donor age with respect to severity of HCV recurrence after liver transplantation.
    Liver Transpl, 11(4): 386-95. [Abstract] [Full-text]
41. Wilson's disease in children: 37-year experience and revised King's score for liver transplantation.
    Liver Transpl, 11(4): 441-8. [Abstract] [Full-text]
42. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence.
    Liver Transpl, 11(4): 402-9. [Abstract] [Full-text]
43. Alcohol recidivism impairs long-term patient survival after orthotopic liver transplantation for alcoholic liver disease.
    Liver Transpl, 11(4): 420-6. [Abstract] [Full-text]
44. Hepatocyte expression of minichromosome maintenance protein-2 predicts fibrosis progression after transplantation for chronic hepatitis C virus: a pilot study.
    Liver Transpl, 11(4): 427-33. [Abstract] [Full-text]
45. Fatal course of parvovirus B19-associated myocarditis in a female liver transplant recipient.
    Liver Transpl, 11(4): 463-6. [Abstract] [Full-text]
46. Hepatic vein anatomy of the medial segment for living donor liver transplantation using extended right lobe graft.
    Liver Transpl, 11(4): 449-55. [Abstract] [Full-text]
47. Liver transplant in a patient with a ventriculoperitoneal shunt.
    Liver Transpl, 11(4): 467-8. [Abstract] [Full-text]
48. Prediction of fibrosis in HCV-infected liver transplant recipients with a simple noninvasive index.
    Liver Transpl, 11(4): 456-62. [Abstract] [Full-text]
49. Post-transplant lymphoproliferative disorder of the cervix.
    Gynecol Oncol, 97(1): 271-5. [Abstract] [Full-text]
50. Molecular case report: IgVH analysis in acute humoral and cellular liver allograft rejection suggests a selected accumulation of effector B cells and plasma cells.
    Virchows Arch, 446(3): 325-32. [Abstract] [Full-text]
51. A clinically based discrete-event simulation of end-stage liver disease and the organ allocation process.
    Med Decis Making, 25(2): 199-209. [Abstract] [Full-text]

© 2005-2008 Liver Transplant Research Today. All Rights Reserved.